Auriga
Auriga USA is a research and trading platform that focuses on growth sectors within the Health Care and Technology verticals. We operate out of our main office in New York City, and also have satellite offices in Boston, San Francisco, Philadelphia, San Diego, and Washington D.C. This regional network helps us to keep abreast of key corporate developments, enhance client relationships, and provide more efficient product distribution to meet clients' investment needs. The firm is committed to providing our clients with critical information flow, investment ideas, and access to industry experts.
-
Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); Generic Leucovorin Shortage Continues
-
Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); February Demand for Fusilev Hits Record
-
Canaccord Genuity Maintains a 'Buy' on Spectrum Pharmaceuticals (SPPI); Mixed Q4 Results
-
Auriga Reiterates a 'Buy' on Spectrum Pharmaceuticals (SPPI); Share Price Decline Unwarranted; Fundamentals Remain Strong
-
Auriga Starts Spectrum Pharmaceuticals (SPPI) at Buy; Fast-Growing Cancer Therapy Company
